Implant Practice US provides continuing education and other valuable resources to help you build upon your expertise in implantology. Our continuing education is updated regularly and accessible any time, from anywhere.
Purchase a subscription today!

Implant dentistry enters new era with launch of Nobel Biocare Xeal™ and TiUltra™ surfaces in the United States

January 12, 2021, Yorba Linda, California, USA, Nobel Biocare invites dental professionals to join the Mucointegration™ era with the launch of the Xeal and TiUltra surfaces in the United States. These new surfaces are applied to implants and abutments, which optimizes tissue integration at every level.

New Xeal abutments feature next-generation surface chemistry designed to promote soft-tissue attachment. In a clinical study with a two-year follow-up, the Xeal surface demonstrated a significant increase in soft-tissue height compared to machined abutment surfaces. After its wide success and adoption in Europe, dental professionals in the United States will now be able to see and experience the pioneering Mucointegration™ surface as it is made available for Nobel Biocare’s On1™ Base and Multi-unit Abutment.

The TiUltra surface promotes early osseointegration. The surface was developed to further promote early osseointegration and support bone stability. With an ultra-hydrophilic, multi-zoned implant surface, the TiUltra surface is taking anodization technology one step further. Roughness, porosity, and surface chemistry are important factors for tissue integration. Surface chemistry, in particular, plays a vital role in enhancing cellular attachment.

The TiUltra surface is now available through Nobel Biocare’s NobelActive®, NobelParallel™ Conical Connection, and NobelReplace® Conical Connection implants. When combined with the Xeal abutment surface, dental professionals will have a complete solution for tissue integration.

”Dental professionals are now able to experience the Xeal and TiUltra surfaces in their practice and discover how important the soft-tissue barrier becomes in protecting the underlying bone. It is this feature that promotes the basis for long-term tissue health and stability, which will not only be appreciated by the clinician, but by the patient as well.said Patrik Eriksson, Nobel Biocare’s President.

Press contact:
John vanDyck
Vice President, Marketing – USA
Nobel Biocare USA, LLC

About Nobel Biocare

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive® and NobelParallel™), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), digital solutions for treatment planning (DTX Studio™ suite) and guided surgery, as well as biomaterials (creos™ regenerative solutions). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials.

Stay Relevant with Implant Practice US

Join our email list for CE courses and webinars, articles and mores

Read our following terms and conditions before subscribing.

Terms and Conditions checkbox is required.
Something went wrong. Please check your entries and try again.


Implant Practice US is a leading dental journal and publication for dental implantology continuing education, oral implantology case studies, and more. Subscribe to Implant Practice US today!


Earn dental continuing education credits as an Implant Practice US subscriber. Log in for online dental CE credits now!


Copyright © 2021 Orthodontic Practice US - Dental Journal and Online Dental CE | MedMark LLC
15720 North Greenway Hayden Loop, Suite #9 Scottsdale, AZ 85260 | All rights Reserved | Privacy Policy | Terms & Conditions

Scroll to Top